Sabine Vieillot
Perpignan, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
First-Line Pembrolizumab Efficacy in Octogenarians With NSCLCs Expressing ≥ 50% PD-L1 (ESCKEYP GFPC 05-2018).
Journal: Clinical lung cancer
Published: November 17, 2024
A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA-B GFPC 04-2020Study).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 05, 2024
Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study).
Journal: Targeted oncology
Published: October 21, 2023
Three-Year Overall Survival of Patients With Advanced Non-Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study).
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: August 03, 2023
Brain radiotherapy in patients treated for a newly diagnosed primary central nervous system lymphoma: professional practice evaluation in 19 French centers.
Journal: Acta oncologica (Stockholm, Sweden)
Published: June 20, 2023
First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study).
Journal: Cancer immunology, immunotherapy : CII
Published: January 18, 2022
Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial.
Journal: Clinical genitourinary cancer
Published: February 20, 2021
Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus "at progression" cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis.
Journal: Therapeutic advances in medical oncology
Published: December 28, 2020
Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 25, 2019
Management of locally advanced anal canal carcinoma with modulated arctherapy and concurrent chemotherapy
Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: October 21, 2014
IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center.
Journal: Radiation oncology (London, England)
Published: November 04, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026